Skip to main navigation Skip to search Skip to main content

Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC)

  • Gaurav Gupta
  • , Md Sadique Hussain
  • , Kumud Pant
  • , Haider Ali
  • , Riya Thapa
  • , Asif Ahmad Bhat
  • Chitkara University
  • Uttaranchal University
  • Graphic Era
  • Graphic Era Hill University
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
  • Kyrgyz State Medical College

Research output: Contribution to journalLetterpeer-review

21 Scopus citations
Original languageEnglish
Pages (from-to)108-112
Number of pages5
JournalCurrent Cancer Drug Targets
Volume25
Issue number2
DOIs
StatePublished - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibody-drug conjugates
  • Sacituzumab govitecan
  • Trop2 antigen
  • clinical trial
  • triple-negative breast cancer

Cite this